İYTE

Yayınlar

2026

  • Tenekeci S, Sezgin E, Tekir S. A Contrastive Learning Framework for Efficient Viral Escape Prediction. IEEE Trans Comput Biol Bioinform. 2026 Mar 17;PP. doi: 10.1109/TCBBIO.2026.3674782. Epub ahead of print. PMID: 41843532.

2025

  • Meliscan Arlı and Efe Sezgin. Comparative Molecular Evolution of the Most Dominant and Virulent Recombinant Sars-CoV-2 Variant XE and its Parent Lineage Viruses BD.1 and BA. 2.30. Cohesive J Microbiol Infect Dis. 7(5). CJMI. 000674. 2025. DOI: 10.31031/CJMI.2025.07.000674. CJMI.000674
  • Hunt P.W., Olshen A.B., Murad N., Ambayec G.C., Sezgin E., Schneider M.F. & Jabs D.A. (2025). – Plasma Proteomic Markers of Interleukin-1β Pathway Associated with Incident  Age-Related Macular Degeneration in Persons with AIDS. Ophthalmol. Sci., 5 (5), 100794. doi:10.1016/j.xops.2025.100794.
  • Krause-Kyora B., Silva N.A. da, Kaplan E., Kolbe D., Wohlers I., Busch H., Ellinghaus D., Caliebe A., Sezgin E., Nebel A. & Schreiber S. (2025). – Neolithic introgression of IL23R-related protection against chronic inflammatory  bowel diseases in modern Europeans. EBioMedicine, 113, 105591. doi:10.1016/j.ebiom.2025.105591.
  • Soran A, Göktepe B, Demirors B, Aytac O, Ozbas S, Dogan L, Can Trablus D, Al-Azhri J, Senol K, Zaveri S, Meas S, Demirci U, Karanlik H, Soyder A, Dag A, Bilici A, Dogan M, Sendur MAN, Koksal H, Gulcelik MA, Cabioglu N, Yeniay L, Utkan Z, Karadurmus N, Daglar G, Simsek T, Yildiz B, Uras C, Tukenmez M, Ozaslan C, Karaman N, Isik A, Sezgin E, Ozmen V, Lucci A. Locoregional Treatment in De Novo Bone-Only Metastatic Breast Cancer: Prospective, Multi-Institutional Real-World Data, BOMETIN, Protocol MF14-1a. Curr Oncol. 2025 Oct 3;32(10):556. doi: 10.3390/curroncol32100556. PMID: 41149476; PMCID: PMC12564594.
  • Goktepe B., Demirors B., Senol K., Ozbas S., Sezgin E., Lucci A. & Soran A. (2025). – A Pragmatic Grouping Model for Bone-Only De Novo Metastatic Breast Cancer (MetS  Protocol MF22-03). Cancers (Basel)., 17 (12). doi:10.3390/cancers17122033.
  • Soran A., Gultekin M.B., Venkatesulu B.P., Barry P.N., King C., Bhargava R., Karanlik H., Yildiz F., Soyder A., Goktepe B., Senol K., Guzel C., Sen E., Yeniay L., Dag A., Trabulus D.C., Coskun A., Veliyeva H., Utkan Z., Demirors B., Sezgin E. & Vargo J.A. (2025). – Biologically Informed Decision-Making for PMRT in pT3N0M0 Luminal Breast Cancers  (Protocol MF22-02): International Multicenter Real-World Data. Clin. Breast Cancer, 25 (7), e887–e896. doi:10.1016/j.clbc.2025.04.012.
  • Ozcinar B., Aribal E., Cabioglu N., Gurdal S.O., Varol G., Akyurt N., Sezgin E. & Ozmen V. (2025). – Long-term outcomes of Türkiye’s first population-based mammography screening  program: a decade of breast cancer detection and survival analysis in Bahçeşehir. BMC Womens. Health, 25 (1), 5. doi:10.1186/s12905-024-03521-1.

2024

  • Dokur M., Uysal E., Kucukdurmaz F., Altinay S., Polat S., Batcioglu K., Yilmaztekin Y., Guney T., Sapmaz Ercakalli T., Yaylali A., Sezgin E., Cetin Z., Saygili E.I., Barut O., Kazimoglu H., Maralcan G., Koc S., Sokucu M. & Dokur Yeni S.N. (2024). – Targeting the PANoptosome Using Necrostatin-1 Reduces PANoptosis and Protects the  Kidney Against Ischemia-Reperfusion Injury in a Rat Model of Controlled Experimental Nonheart-Beating Donor. Transplant. Proc., 56 (10), 2268–2279. doi:10.1016/j.transproceed.2024.10.047.
  • Bilgen N., Güvendi M., Sezgin E., Can H., Köseoğlu A.E., Erkunt Alak S., Döşkaya M. & Ün C. (2024). – Mitotyping of random bred cats and pure breed cats (Turkish Angora and Turkish  Van) using non-repetitive mitochondrial DNA control region. Gene, 892, 147849. doi:10.1016/j.gene.2023.147849.
  • Sezgin E., Schneider M.F., Hunt P.W., Beck-Engeser G., Ambayac G.C. & Jabs D.A. (2024). – Genetic factors associated with age-related macular degeneration modulating  plasma inflammatory biomarker levels in patients with AIDS. Ophthalmic Genet., 45 (4), 337–342. doi:10.1080/13816810.2024.2330380.
  • Solak H.M., Kreisinger J., Čížková D., Sezgin E., Schmiedová L., Murtskhvaladze M., Henning Y., Çolak F., Matur F. & Yanchukov A. (2024). – Altitude shapes gut microbiome composition accounting for diet, thyroid hormone  levels, and host genetics in a subterranean blind mole rat. Front. Microbiol., 15, 1476845. doi:10.3389/fmicb.2024.1476845.
  • Sanli A.N., Tekcan Sanli D.E., Golshan M., Sezgin E., Celik V. & Aydogan F. (2024). – Comparison of magnetic seed and RFID methods in the localization of non-palpable  breast lesions. J. Cancer Res. Ther., 20 (5), 1435–1439. doi:10.4103/jcrt.jcrt_2253_22.
  • Bozkurt B., Terlemez G. & Sezgin E. (2023). – Basidiomycota species in Drosophila gut are associated with host fat metabolism. Sci. Rep., 13 (1). doi:10.1038/s41598-023-41027-2.

2023

  • Sezgin E., Teferedegn E.Y., Ün C. & Yaman Y. (2023). – Correction to: Excessive replacement changes drive evolution of global sheep prion protein (PRNP) sequences (Heredity, (2022), 128, 5, (377-385), 10.1038/s41437-022-00520-6). Heredity (Edinb)., 130 (1). doi:10.1038/s41437-022-00572-8.
  • Matur F., Keskin E. & Sezgin E. (2023). – Editorial: Population genomics and adaptation to novel environments: challenges and opportunities. Front. Ecol. Evol., 11. doi:10.3389/fevo.2023.1190218.
  • Soran A., Ozbas S., Ozcinar B., Isik A., Dogan L., Senol K., Dag A., Karanlik H., Aytac O., Cakmak G.K., Dalci K., Dogan M., Sezer Y.A., Gokgoz S., Ozyar E. & Sezgin E. (2023). – Correction: Intervention for Hepatic and Pulmonary Metastases in Breast Cancer Patients: Prospective, Multi-institutional Registry Study–IMET, Protocol MF 14-02 (Annals of Surgical Oncology, (2022), 29, 10, (6327-6336), 10.1245/s10434-022-12239-z). Ann. Surg. Oncol., 30 (2). doi:10.1245/s10434-022-12931-0.
  • Sezgin E. & Tekin B. (2023). – Molecular evolution and population genetics of glutamate decarboxylase acid resistance pathway in lactic acid bacteria. Front. Genet., 14. doi:10.3389/fgene.2023.1027156.

2022

  • Uysal E., Dokur M., Kucukdurmaz F., Altınay S., Polat S., Batcıoglu K., Sezgin E., Sapmaz Erçakallı T., Yaylalı A., Yılmaztekin Y., Cetın Z., Saygılı İ., Barut O., Kazımoglu H., Maralcan G., Koc S., Guney T., Eser N., Sökücü M. & Dokur S.N. (2022). – Targeting the PANoptosome with 3,4-Methylenedioxy-β-Nitrostyrene, Reduces PANoptosis and Protects the Kidney against Renal İschemia-Reperfusion Injury. J. Investig. Surg., 35 (11–12). doi:10.1080/08941939.2022.2128117.
  • Ozmen V., Caglayan A.O., Yararbas K., Ordu C., Aktepe F., Ozmen T., Ilgun A.S., Soybir G., Alco G., Tsaousis G.N., Papadopoulou E., Agiannitopoulos K., Pepe G., Kampouri S., Nasioulas G., Sezgin E. & Soran A. (2022). – Importance of multigene panel test in patients with consanguineous marriage and family history of breast cancer. Oncol. Lett., 23 (4). doi:10.3892/ol.2022.13238.
  • Isik A., Soran A., Grasi A., Barry N. & Sezgin E. (2022). – Lymphedema after Sentinel Lymph Node Biopsy: Who Is at Risk? Lymphat. Res. Biol., 20 (2). doi:10.1089/lrb.2020.0093.
  • Sezgin E., Teferedegn E.Y., Ün C. & Yaman Y. (2022). – Excessive replacement changes drive evolution of global sheep prion protein (PRNP) sequences. Heredity (Edinb)., 128 (5). doi:10.1038/s41437-022-00520-6.
  • Isik A., Wysocki A.P., Memiş U., Sezgin E., Yezhikova A. & Islambekov Y. (2022). – Factors Associated with the Occurrence and Healing of Umbilical Pilonidal Sinus: A Rare Clinical Entity. Adv. Ski. Wound Care, 35 (8). doi:10.1097/01.ASW.0000833608.27136.d1.
  • Soran A., Toktas O., Grassi A. & Sezgin E. (2022). – Adding Pneumatic Compression Therapy in Lower Extremity Lymphedema Increases Compliance of Treatment, while Decreasing the Infection Rate. Lymphat. Res. Biol., 20 (3). doi:10.1089/lrb.2020.0086.
  • Sezgin E. & Kaplan E. (2022). – Diverse selection pressures shaping the genetic architecture of behçet disease susceptibility. Front. Genet., 13. doi:10.3389/fgene.2022.983646.
  • Soran A., Ozbas S., Ozcinar B., Isik A., Dogan L., Senol K., Dag A., Karanlik H., Aytac O., Karadeniz Cakmak G., Dalci K., Dogan M., Sezer Y.A., Gokgoz S., Ozyar E. & Sezgin E. (2022). – Intervention for Hepatic and Pulmonary Metastases in Breast Cancer Patients: Prospective, Multi-institutional Registry Study–IMET, Protocol MF 14-02. Ann. Surg. Oncol., 29 (10). doi:10.1245/s10434-022-12239-z.
  • Soran A., Ozbas S., Ozcinar B., Isik A., Dogan L., Senol K., Dag A., Karanlik H., Aytac O., Karadeniz Cakmak G., Dalci K., Dogan M., Sezer Y.A., Gokgoz S., Ozyar E. & Sezgin E. (2022). – ASO Visual Abstract: Intervention for Hepatic and Pulmonary METastases in Breast Cancer Patients-Prospective, Multi-Institutional Registry Study: IMET; Protocol MF 14-02. Ann. Surg. Oncol., 29 (10). doi:10.1245/s10434-022-12320-7.
  • Sezgin E., Terlemez G., Bozkurt B., Bengi G., Akpinar H. & Büyüktorun İ. (2022). – Quantitative real-time PCR analysis of bacterial biomarkers enable fast and accurate monitoring in inflammatory bowel disease. PeerJ, 10. doi:10.7717/peerj.14217.

2021

  • Toktas O., Konca C., Trabulus D.C., Soyder A., Koksal H., Karanlik H., Kamali Polat A., Ozbas S., Yormaz S., Isik A., Sezgin E. & Soran A. (2021). – A novel first-line treatment alternative for noncomplicated idiopathic granulomatous mastitis: Combined i˙ntralesional steroid i˙njection with topical steroid administration. Breast Care, 16 (2). doi:10.1159/000507951.
  • Soran A., Soyder A., Ozbas S., Ozmen V., Karanlik H., Igci A., Muslumanoglu M., Evrensel T., Canturk Z., Utkan Z., Ozaslan C., Uras C., Ugurlu U., Col C., Cabioglu N., Uzunkoy A., Gulluoglu B.M., Erdem E., Konca C. & Sezgin E. (2021). – The role of loco-regional treatment in long-term quality of life in de novo stage IV breast cancer patients: protocol MF07-01Q. Support. Care Cancer, 29 (7). doi:10.1007/s00520-020-05905-z.
  • Soran A., Dogan L., Isik A., Ozbas S., Trabulus D.C., Demirci U., Karanlik H., Soyder A., Dag A., Bilici A., Dogan M., Koksal H., Sendur M.A.N., Gulcelik M.A., Maralcan G., Cabioglu N., Yeniay L., Utkan Z., Simsek T., Karadurmus N., Daglar G., Yildiz B., Uras C., Tukenmez M., Yildirim A., Kutun S., Ozaslan C., Karaman N., Akcay M.N., Toktas O. & Sezgin E. (2021). – The Effect of Primary Surgery in Patients with De Novo Stage IV Breast Cancer with Bone Metastasis Only (Protocol BOMET MF 14-01): A Multi-Center, Prospective Registry Study. Ann. Surg. Oncol., 28 (9). doi:10.1245/s10434-021-09621-8.
  • An P., Sezgin E., Kirk G.D., Duggal P., Binns-Roemer E., Nelson G., Limou S., Natta M.L. Van, Jabs D.A., Estrella M., Kopp J.B. & Winkler C.A. (2021). – APOL1 variant alleles associate with reduced risk for opportunistic infections in HIV infection. Commun. Biol., 4 (1). doi:10.1038/s42003-021-01812-z.
  • Soran A., Ozmen V., Ozbas S., Karanlik H., Muslumanoglu M., Igci A., Canturk N.Z., Utkan Z., Evrensel T., Sezgin E., Ozaslan C., Uras C., Aksaz E., Soyder A., Col C., Cabioglu N., Gulluoglu B.M. & Erdem E. (2021). – Primary Surgery with Systemic Therapy in Patients with de Novo Stage IV Breast Cancer: 10-year Follow-up; Protocol MF07-01 Randomized Clinical Trial. J. Am. Coll. Surg., 233 (6). doi:10.1016/j.jamcollsurg.2021.08.686.
  • Soran A., Sezgin E., Ozbas S. & Dogan L. (2021). – Reply: The Effect of Primary Surgery in Patients with Stage IV Breast Cancer with Bone Metastasis Only (Protocol BOMET MF 14-01): A Multi-center, Registry Study. Ann. Surg. Oncol., 28. doi:10.1245/s10434-021-10396-1.
  • Soran A., Ozbas S., Dogan L., Isik A. & Sezgin E. (2021). – Correspondence to “Locoregional therapy in de novo metastatic breast cancer: Systematic review and meta-analysis, written by Reinhorn D et al. In The Breast Journal 58 (2021) 173–181.” Breast, 60. doi:10.1016/j.breast.2021.10.002.

2020

  • Ceylan S.M., Uysal E., Sokucu M., Sezgin E., Kanmaz M.A., Yurtseven D.G. & Bilal N. (2020). – The Effects of Halofuginone on Wound Healing in the Rat Nasal Mucosa. Am. J. Rhinol. Allergy, 34 (1). doi:10.1177/1945892419866312.
  • Kirdak T., Uysal E., Sezgin E., Cecen G.S. & Cavun S. (2020). – Inflammatory response markers in rats undergoing abdominal surgical procedures. Ann. Gastroenterol., 33 (5). doi:10.20524/aog.2020.0511.
  • Aydogan T., Sezgin E., Ilvan S., Yilmaz O.C., Aslan N., Golshan M. & Aydogan F. (2020). – Comparison of Radio-guided Occult Lesion Localization (ROLL) and Magnetic Occult Lesion Localization (MOLL) for Non-palpable Lesions: A Phantom Model Study. Clin. Breast Cancer, 20 (1). doi:10.1016/j.clbc.2019.09.002.
  • Ceylan S.M., Dişikırık İ., Kanmaz M.A., Yıldırım A. & Sezgin E. (2020). – Hot nasal packing with hot saline irrigation for hemostasis after adenoidectomy: A prospective randomized controlled study. Int. J. Pediatr. Otorhinolaryngol., 130. doi:10.1016/j.ijporl.2019.109792.
  • Soran A., Tane K., Sezgin E. & Bhargava R. (2020). – The Correlation of Magee EquationsTM and Oncotype DX® Recurrence Score From Core Needle Biopsy Tissues in Predicting Response to Neoadjuvant Chemotherapy in ER+ and HER2- Breast Cancer. Eur. J. Breast Heal., 16 (2). doi:10.5152/ejbh.2020.5338.

2019

  • Sezgin E., An P. & Winkler C.A. (2019). – Host genetics of cytomegalovirus (CMV) pathogenesis. Front. Genet., 10 (JUN). doi:10.3389/fgene.2019.00616.
  • Ceylan S.M., Uysal E., Altinay S., Sezgin E., Bilal N., Petekkaya E., Dokur M., Kanmaz M.A. & Gulbagci M.E. (2019). – Protective and therapeutic effects of milrinone on acoustic trauma in rat cochlea. Eur. Arch. Oto-Rhino-Laryngology, 276 (7). doi:10.1007/s00405-019-05417-5.

2018

  • Sezgin E, Van Natta ML, Thorne JE, Puhan MA, Jabs DA, Longitudinal Studies of the Ocular Complications of ARG. Secular trends in opportunistic infections, cancers and mortality in patients with AIDS during the era of modern combination antiretroviral therapy. HIV Med. 2018;19(6):411-419. PDF
  • Uysal E, Soran A, Sezgin E, Granulomatous Mastitis Study G. Factors related to recurrence of idiopathic granulomatous mastitis: what do we learn from a multicentre study? ANZ J Surg. 2018;88(6):635-639.PDF
  • Soran A., Ozmen V., Ozbas S., Karanlik H., Muslumanoglu M., Igci A., Canturk Z., Utkan Z., Ozaslan C., Evrensel T., Uras C., Aksaz E., Soyder A., Ugurlu U., Col C., Cabioglu N., Bozkurt B., Uzunkoy A., Koksal N., Gulluoglu B.M., Unal B., Atalay C., Yildirim E., Erdem E., Salimoglu S., Sezer A., Koyuncu A., Gurleyik G., Alagol H., Ulufi N., Berberoglu U., Dulger M., Cengiz O., Sezgin E., Johnson R. Randomized Trial Comparing Resection of Primary Tumor with No Surgery in Stage IV Breast Cancer at Presentation: Protocol MF07-01. Ann Surg Oncol. 2018;25(11):3141-3149.PDF

2017

  • Uysal E, Turel K, Sezgin E. Evaluation of factors that affecting mortality in urgent redo-laparotomies. Medical Science and Discovery. 2017;4(5):35-43.PDF
  • Uysal E, Sezgin E, Bakır H, Gurer A, Sokucu M. Is Routine Histopathological Gallbladder Examination Necessary After Cholecystectomy? Evaluation of the Results of 1,366 Cholecystectomy Specimens in Single Center. Konuralp Tıp Dergisi. 2017;9(3):243-249.PDF
  • Uysal E, Ceylan SM, Sezgin E, et al. Evaluation of Hemocytometer Parameters as Potential Biomarkers in Benign Multinodular Goiter and Papillary Thyroid Carcinoma. Iran Red Crescent Med J. 2017;19(12):e58295.PDF

2016

  • Unluturk U, Sezgin E, Yildiz BO. Evolutionary determinants of polycystic ovary syndrome: part 1. Fertil Steril. 2016;106(1):33-41.PDF
  • Soran A., Bhargava R., Johnson R., Ahrendt G., Bonaventura M., Diego E., McAuliffe P.F., Serrano M., Menekse E., Sezgin E., McGuire K.P. The impact of Oncotype DX(R) recurrence score of paraffin-embedded core biopsy tissues in predicting response to neoadjuvant chemotherapy in women with breast cancer. Breast Dis. 2016;36(2-3):65-71.PDF

2015

  • Kasembeli A.N., Duarte R., Ramsay M., Mosiane P., Dickens C., Dix-Peek T., Limou S., Sezgin E., Nelson G.W., Fogo A.B., Goetsch S., Kopp J.B., Winkler C.A., Naicker S. APOL1 Risk Variants Are Strongly Associated with HIV-Associated Nephropathy in Black South Africans. J Am Soc Nephrol. 2015;26(11):2882-2890.PDF
  • Jabs DA, Van Natta ML, Sezgin E, Pak JW, Danis R, Studies of the Ocular Complications of ARG. Prevalence of intermediate-stage age-related macular degeneration in patients with acquired immunodeficiency syndrome. Am J Ophthalmol. 2015;159(6):1115-1122 e1111.PDF

2014

  • Svitin A., Malov S., Cherkasov N., Geerts P., Rotkevich M., Dobrynin P., Shevchenko A., Guan L., Troyer J., Hendrickson S., Dilks H.H., Oleksyk T.K., Donfield S., Gomperts E., Jabs D.A., Sezgin E., Van Natta M., Harrigan P.R., Brumme Z.L., O’Brien S.J. GWATCH: a web platform for automated gene association discovery analysis. Gigascience. 2014;3:18.PDF

2013

  • Branch A.D., Drye L.T., Van Natta M.L., Sezgin E., Fishman S.L., Dieterich D.T., Meinert C.L., Jabs D.A.. Evaluation of hepatitis C virus as a risk factor for HIV-associated neuroretinal disorder. Clin Infect Dis. 2013;57(11):1618-1625.PDF

2012

  • Tang M., Lautenberger J.A., Gao X., Sezgin E., Hendrickson S.L., Troyer J.L., David V.A., Guan L., McIntosh C.E., Guo X., Zheng Y., Liao J., Deng H., Malasky M., Kessing B., Winkler C.A., Carrington M., De The G., Zeng Y., O’Brien S.J. The principal genetic determinants for nasopharyngeal carcinoma in China involve the HLA class I antigen recognition groove. PLoS Genet. 2012;8(11):e1003103.PDF
  • Tang M., Lautenberger J.A., Gao X., Sezgin E., Hendrickson S.L., Troyer J.L., David V.A., Guan L., McIntosh C.E., Guo X., Zheng Y., Liao J., Deng H., Malasky M., Kessing B., Winkler C.A., Carrington M., De The G., Zeng Y., O’Brien S.J. F5-The Principal Genetic Determinants for Nasopharyngeal Carcinoma in China Involve HLA Class I Antigen Recognition Groove. JAIDS Journal of Acquired Immune Deficiency Syndromes. 2012;59:88.PDF
  • Limou S., Delaneau O., van Manen D., An P., Sezgin E., Le Clerc S., Coulonges C., Troyer J.L., Veldink J.H., van den Berg L.H., Spadoni J.L., Taing L., Labib T., Montes M., Delfraissy J.F., Schachter F., O’Brien S.J., Buchbinder S., van Natta M.L., Jabs D.A., Froguel P., Schuitemaker H., Winkler C.A., Zagury J.F. Multicohort genomewide association study reveals a new signal of protection against HIV-1 acquisition. J Infect Dis. 2012;205(7):1155-1162.PDF

2011

  • Troyer J.L., Nelson G.W., Lautenberger J.A., Chinn L., McIntosh C., Johnson R.C., Sezgin E., Kessing B., Malasky M., Hendrickson S.L., Li G., Pontius J., Tang M., An P., Winkler C.A., Limou S., Le Clerc S., Delaneau O., Zagury J.F., Schuitemaker H., van Manen D., Bream J.H., Gomperts E.D., Buchbinder S., Goedert J.J., Kirk G.D., O’Brien S.J. Genome-wide association study implicates PARD3B-based AIDS restriction. J Infect Dis. 2011;203(10):1491-1502.PDF
  • Sezgin E, van Natta ML, Ahuja A, et al. Association of host genetic risk factors with the course of cytomegalovirus retinitis in patients infected with human immunodeficiency virus. Am J Ophthalmol. 2011;151(6):999-1006 e1004.PDF
  • An P., Li R., Wang J.M., Yoshimura T., Takahashi M., Samudralal R., O’Brien S.J., Phair J., Goedert J.J., Kirk G.D., Troyer J.L., Sezgin E., Buchbinder S.P., Donfield S., Nelson G.W., Winkler C.A. Role of exonic variation in chemokine receptor genes on AIDS: CCRL2 F167Y association with pneumocystis pneumonia. PLoS Genet. 2011;7(10):e1002328.PDF

2010

  • Somel M, Sezgin E. Genetic Footprints of Natural Selection and Drift in Human Evolution. Hacettepe Journal of Biology and Chemistry. 2010;38(3):193 – 220.PDF
  • Sezgin E, Jabs DA, Hendrickson SL, et al. Effect of host genetics on the development of cytomegalovirus retinitis in patients with AIDS. J Infect Dis. 2010;202(4):606-613.PDF
  • Sezgin E, Hendrickson SL, Jabs DA, et al. Effect of host genetics on incidence of HIV neuroretinal disorder in patients with AIDS. J Acquir Immune Defic Syndr. 2010;54(4):343-351.PDF
  • Sezgin E, Drosdak A, McIntosh C, et al. Examination of disease-based selection, demographic history and population structure in European Y-chromosome haplogroup I. J Hum Genet. 2010;55(9):613-620.PDF
  • Hendrickson S.L., Lautenberger J.A., Chinn L.W., Malasky M., Sezgin E., Kingsley L.A., Goedert J.J., Kirk G.D., Gomperts E.D., Buchbinder S.P., Troyer J.L., O’Brien S.J. Genetic variants in nuclear-encoded mitochondrial genes influence AIDS progression. PLoS One. 2010;5(9):e12862.PDF

2009

  • Sezgin E, Lind JM, Shrestha S, et al. Association of Y chromosome haplogroup I with HIV progression, and HAART outcome. Hum Genet. 2009;125(3):281-294.PDF
  • Merritt T.J., Kuczynski C., Sezgin E., Zhu C.T., Kumagai S., Eanes W.F., 2009. “Quantifying interactions within the NADP(H) enzyme network in Drosophila melanogaster”, Genetics, 182(2), 565-574. PDF

2008

  • Hendrickson S.L., Hutcheson H.B., Ruiz-Pesini E., Poole J.C., Lautenberger J., Sezgin E., Kingsley L., Goedert J.J., Vlahov D., Donfield S., Wallace D.C., O’Brien S.J. Mitochondrial DNA haplogroups influence AIDS progression. AIDS. 2008;22(18):2429-2439.PDF

2007

  • Flowers JM, Sezgin E, Kumagai S, et al. Adaptive evolution of metabolic pathways in Drosophila. Mol Biol Evol. 2007;24(6):1347-1354.PDF

2006

  • Merritt TJ, Sezgin E, Zhu CT, Eanes WF. Triglyceride pools, flight and activity variation at the Gpdh locus in Drosophila melanogaster. Genetics. 2006;172(1):293-304.PDF
  • Eanes WF, Merritt TJ, Flowers JM, Kumagai S, Sezgin E, Zhu CT. Flux control and excess capacity in the enzymes of glycolysis and their relationship to flight metabolism in Drosophila melanogaster. Proc Natl Acad Sci U S A. 2006;103(51):19413-19418.PDF

2004

  • Sezgin E, Duvernell DD, Matzkin LM, et al. Single-locus latitudinal clines and their relationship to temperate adaptation in metabolic genes and derived alleles in Drosophila melanogaster. Genetics. 2004;168(2):923-931.PDF